Drug Profile
89 07
Latest Information Update: 21 Mar 2007
Price :
$50
*
At a glance
- Originator Beijing Medical University
- Class Aminoglycosides; Antibacterials
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 21 Mar 2007 Discontinued - Preclinical for Bacterial infections in China (unspecified route)
- 14 Apr 1997 No-Development-Reported for Bacterial infections in China (Unknown route)
- 12 Oct 1995 Preclinical development for Bacterial infections in China (Unknown route)